Clinical Trial Update: Restoring Sinus Rhythm With Cardiac Resynchronization in Patients With Atrial Fibrillation (ReSync AF) [NA]

View source ↗

Summary

The ReSync AF trial evaluating cardiac resynchronization therapy to restore sinus rhythm in patients with heart failure and atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Drugs mentioned

• Cardiac Resynchronization Therapy (CRT) device

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure, Atrial Arrhythmia | NA | Status: COMPLETED